Our first Health Technology Assessment and Evidence Synthesis Bulletin of 2024 is out now. It provides a brief summary of our key activities and achievements for the first quarter of the year, including:

• What is health technology assessment at HIQA?
• Public consultation of our draft HTA on the addition of shingles vaccination to the adult vaccination programme.
• Ongoing work on a HTA of the use of enhanced inactivated flu vaccines in those aged 65 years and older.
• Our review of advances in the development and implementation of clinical practice guidance, as part of HIQA’s HRB-CICER function.
• Our rare disease strategy review.
• Our contributions to the 10th annual conference of the SPHeRE Network.